← Back to Search

Other

Enhanced Recovery After Surgery Protocol for Idiopathic Scoliosis

N/A
Waitlist Available
Led By Andrew Abumoussa, MD MSc
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up preop to post op comparison of odi at 4 days, 2 weeks, 6 weeks, 12 weeks and 6 months.
Awards & highlights

Study Summary

This trialwill evaluate a protocol to improve outcomes in complex spine surgery for Adult Spinal Deformity. It will create new standards for minimally invasive surgery.

Eligible Conditions
  • Idiopathic Scoliosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~preop to post op comparison of odi at 4 days, 2 weeks, 6 weeks, 12 weeks and 6 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and preop to post op comparison of odi at 4 days, 2 weeks, 6 weeks, 12 weeks and 6 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Length of Stay
Secondary outcome measures
30 Day Readmission
30 Day Reoperations
90 Day Readmissions
+16 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ERASExperimental Treatment1 Intervention
Enhanced recovery after surgery protocol is applied to the patients undergoing deformity correction
Group II: ControlActive Control1 Intervention
Standard post op complex spine orders placed for patients undergoing deformity correction

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,504 Previous Clinical Trials
4,187,652 Total Patients Enrolled
North Carolina Spine SocietyUNKNOWN
Andrew Abumoussa, MD MScPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Media Library

Enhanced Recovery After Surgery Protocol (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04538092 — N/A
Idiopathic Scoliosis Research Study Groups: ERAS, Control
Idiopathic Scoliosis Clinical Trial 2023: Enhanced Recovery After Surgery Protocol Highlights & Side Effects. Trial Name: NCT04538092 — N/A
Enhanced Recovery After Surgery Protocol (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04538092 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been accepted as participants in this research endeavor?

"Affirmative. Information available on clinicaltrials.gov confirms that this research study, which was originally published on September 14th 2020, is presently accepting applications from participants. Approximately 50 patients need to be recruited across 1 medical centre."

Answered by AI

Does this research project need more participants at this time?

"Yes, the information on clinicaltrials.gov confirms that this medical trial is presently recruiting patients. Initially posted on September 14th 2020 and most recently edited on October 11th 2022, 50 participants need to be enrolled from 1 site for it to proceed."

Answered by AI

Who else is applying?

What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Met criteria
~2 spots leftby Apr 2025